CAS Number 137328-52-0 IUPHAR/BPS 180 Formula C24H33N3O2 Molar mass 395.54 g/mol | PubChem CID 9822062 ChemSpider 7997811 3D model (Jmol) Interactive image | |
![]() | ||
LY-215,840 is an ergoline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.
References
LY-215,840 Wikipedia(Text) CC BY-SA